Skip to main content

Table 1 Baseline criteria of both study groups

From: The use of tamsulosin in the treatment of 10–15 mm lower ureteral stones in adults: a double-blinded randomized controlled trial

Variable

Tamsulosin group (N = 40)

Control group (N = 40)

p value

Age median (range) years

34.5 (28, 45)

38 (29.5, 46)

0.9

Sex: n (%)

   

 Male

28 (70)

29 (72.5)

0.8

 Female

12 (30)

11 (27.5)

 

Laterality: n (%)

   

 Right-sided

22 (55)

24 (60)

0.7

 Left-sided

18 (45)

16 (40)

 

Stone length median (range) mm

11 (10–12.5)

10.5 (10–14)

0.4

Stone width median (range) mm

6 (4.5–7.5)

6 (5–8)

0.16

Radiopaque stone n (%)

38 (95)

37 (92.5)

0.9

Stone density median (range) HF units

1050 (720–1350)

950 (650–1250)

0.6

Degree of hydronephrosis (HN)

   

 n (%) No HN (SFU grade0)

8 (20)

5 (12.5)

0.4

 n (%) Mild HN (SFU grade1,2)

27 (67.5)

31(77.5)

 

 n (%) Moderate HN (SFU grade3)

5 (12.5)

4 (10)

 
  1. SFU society of fetal urology